Centers of Educational Expertise
CME Dinner Meetings
A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi
WellPoint's Obamacare business making a profit, so far
UnitedHealth: New hepatitis C drug costs far more than forecast
U.S. drug industry group defends price of Gilead hepatitis drug
Gilead offers Egypt new hepatitis C drug at 99 percent discount
Big Pharma pushes for U.S. action against India over patents
CME Dinner Meeting
Board of Trustees
Board of Advisors
Liver News Library
Hep C Link to Care
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation